Patents by Inventor Duncan Cochrane

Duncan Cochrane has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies to IL-17A and uses thereof
    Patent number: 8865166
    Abstract: Binding members, especially antibody molecules, for interleukin 17 (IL-17). The binding members are useful for the treatment of disorders associated with interleukin 17 such as rheumatoid arthritis.
    Type: Grant
    Filed: June 22, 2007
    Date of Patent: October 21, 2014
    Assignee: MedImmune Limited
    Inventors: Duncan Cochrane, Caroline Russell, Matthew Sleeman, Fraser Welsh, Caroline Langham, Maurice Needham, Patrick Dufner
  • IL-18 RECEPTOR ANTIGEN BINDING PROTEINS
    Publication number: 20140093915
    Abstract: Provided herein are IL-18 receptor antigen binding proteins and polynucleotides encoding the same. Expression vectors and host cells comprising the same for production of the antigen binding proteins are also provided. In addition, provided are compositions and methods for diagnosing and treating diseases mediated by IL-18 receptor.
    Type: Application
    Filed: September 3, 2013
    Publication date: April 3, 2014
    Applicant: AMGEN INC.
    Inventors: DIRK E. SMITH, JOHN E. SIMS, JEFFREY T. MCGREW, MAREK Z. KUBIN, DUNCAN COCHRANE, LOUISE CONROY
  • Methods of treatment using IL-18 receptor antigen binding proteins
    Patent number: 8540993
    Abstract: Provided herein are IL-18 receptor antigen binding proteins and polynucleotides encoding the same. Expression vectors and host cells comprising the same for production of the antigen binding proteins are also provided. In addition, provided are compositions and methods for diagnosing and treating diseases mediated by IL-18 receptor.
    Type: Grant
    Filed: August 20, 2012
    Date of Patent: September 24, 2013
    Assignee: AMGEN Inc.
    Inventors: Dirk E. Smith, John E. Sims, Jeffrey T. McGrew, Marek Z. Kubin, Duncan Cochrane, Louise Conroy
  • Binding members for IgE molecules
    Patent number: 8389704
    Abstract: This invention relates to binding members, especially antibody molecules, for IgE. The binding members are useful for, inter alia, treatment of disorders mediated by IgE including allergies and asthma.
    Type: Grant
    Filed: February 15, 2008
    Date of Patent: March 5, 2013
    Assignee: MedImmune Limited
    Inventors: Duncan Cochrane, Suzanne Cohen, Louise Claire Dobson, Fredick Per-Olof Eriksson, David Phillip Monk, Karin Von-Wachenfeldt
  • IL-18 RECEPTOR ANTIGEN BINDING PROTEINS
    Publication number: 20130034569
    Abstract: Provided herein are IL-18 receptor antigen binding proteins and polynucleotides encoding the same. Expression vectors and host cells comprising the same for production of the antigen binding proteins are also provided. In addition, provided are compositions and methods for diagnosing and treating diseases mediated by IL-18 receptor.
    Type: Application
    Filed: August 20, 2012
    Publication date: February 7, 2013
    Inventors: Dirk E. SMITH, John E. Sims, Jeffrey T. McGrew, Marek Z. Kubin, Duncan Cochrane, Louise Conroy
  • IL-18 receptor antigen binding proteins
    Patent number: 8257707
    Abstract: Provided herein are IL-18 receptor antigen binding proteins and polynucleotides encoding the same. Expression vectors and host cells comprising the same for production of the antigen binding proteins are also provided. In addition, provided are compositions and methods for diagnosing and treating diseases mediated by IL-18 receptor.
    Type: Grant
    Filed: July 24, 2008
    Date of Patent: September 4, 2012
    Assignee: Amgen Inc.
    Inventors: Dirk E. Smith, John E. Sims, Jeffrey T. McGrew, Marek Z. Kubin, Duncan Cochrane, Louise Conroy
  • BINDING MEMBERS FOR IGE MOLECULES
    Publication number: 20110212084
    Abstract: This invention relates to binding members, especially antibody molecules, for IgE. The binding members are useful for, inter alia, treatment of disorders mediated by IgE including allergies and asthma.
    Type: Application
    Filed: February 15, 2008
    Publication date: September 1, 2011
    Applicants: ASTRAZENECA AB, MEDIMMUNE LIMITED
    Inventors: Duncan Cochrane, Suzanne Cohen, Louise Claire Dobson, Fredick Per-Olof Eriksson, David Phillip Monk, Karin Von-Wachenfeldt
  • Binding members for IgE molecules
    Patent number: 7959917
    Abstract: This invention relates to binding members, especially antibody molecules, for IgE. The binding members are useful for, inter alia, treatment of disorders mediated by IgE including allergies and asthma.
    Type: Grant
    Filed: February 15, 2008
    Date of Patent: June 14, 2011
    Assignee: MedImmune Limited
    Inventors: Duncan Cochrane, Suzanne Cohen, Claire Louise Dobson, Per-Olof Eriksson, Karin Von Wachenfeldt, Phillip David Monk
  • IL-18 RECEPTOR ANTIGEN BINDING PROTEINS
    Publication number: 20110014201
    Abstract: Provided herein are IL-18 receptor antigen binding proteins and polynucleotides encoding the same. Expression vectors and host cells comprising the same for production of the antigen binding proteins are also provided. In addition, provided are compositions and methods for diagnosing and treating diseases mediated by IL-18 receptor.
    Type: Application
    Filed: July 24, 2008
    Publication date: January 20, 2011
    Applicant: AMGEN INC.
    Inventors: Dirk E. Smith, John E. Sims, Jeffrey T. McGrew, Marek Z. Kubin, Duncan Cochrane, Louise Conroy
  • BINDING MEMBERS FOR IGE MOLECULES
    Publication number: 20100150904
    Abstract: This invention relates to binding members, especially antibody molecules, for IgE. The binding members are useful for, inter alia, treatment of disorders mediated by IgE including allergies and asthma.
    Type: Application
    Filed: February 15, 2008
    Publication date: June 17, 2010
    Applicant: AstraZeneca AB
    Inventors: Duncan Cochrane, Suzanne Cohen, Louise Claire Dobson, Fredick Per-Olof Eriksson, David Phillip Monk, Karin Von-Wachenfeldt
  • BINDING MEMBERS FOR IgE MOLECULES
    Publication number: 20090060919
    Abstract: This invention relates to binding members, especially antibody molecules, for IgE. The binding members are useful for, inter alia, treatment of disorders mediated by IgE including allergies and asthma.
    Type: Application
    Filed: February 15, 2008
    Publication date: March 5, 2009
    Applicant: ASTRAZENECA AB
    Inventors: Duncan Cochrane, Suzanne Cohen, Claire Louise Dobson, Per-Olof Eriksson, Karin Von Wachenfeldt, Phillip David Monk
  • COMPOUNDS
    Publication number: 20080044423
    Abstract: Binding members, especially antibody molecules, for interleukin 17 (IL-17). The binding members are useful for the treatment of disorders associated with interleukin 17 such as rheumatoid arthritis.
    Type: Application
    Filed: June 22, 2007
    Publication date: February 21, 2008
    Inventors: Duncan Cochrane, Caroline Russell, Matthew Sleeman, Fraser Welsh, Caroline Langham, Maurice Needham, Patrick Dufner